Xi Luo - Cansino Biologics Chief Officer

688185 Stock   61.23  0.13  0.21%   

Executive

Xi Luo is Chief Officer of Cansino Biologics
Age 47
Address 401-420, Biomedical Park, Tianjin, China, 300457
Phone86 022 5821 3600
Webhttps://www.cansinotech.com

Cansino Biologics Management Efficiency

The company has return on total asset (ROA) of (0.0792) % which means that it has lost $0.0792 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1362) %, meaning that it generated substantial loss on money invested by shareholders. Cansino Biologics' management efficiency ratios could be used to measure how well Cansino Biologics manages its routine affairs as well as how well it operates its assets and liabilities. At present, Cansino Biologics' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 481.5 M, whereas Total Assets are forecasted to decline to about 6.7 B.

Similar Executives

Showing other executives

EXECUTIVE Age

Sau NgAgricultural Bank of
N/A
Ying YuanChina Life Insurance
46
Fangping JiangShanghai Pudong Development
58
Zhi LiAgricultural Bank of
61
Jianguang WuBank of China
58
Lei ZhangPetroChina Co Ltd
N/A
Qian MengBank of China
59
Zhao CaiBank of China
51
Jiajin LyuIndustrial Bank Co
56
Guoqiang HanAgricultural Bank of
57
Li HuangIndustrial and Commercial
60
Gang WuAgricultural Bank of
59
Xiaolu ZhangPing An Insurance
56
Chaoyang JiangChina Merchants Bank
57
Alex DaiShanghai Pudong Development
N/A
Weiyun GongChina Construction Bank
N/A
Lee WooAgricultural Bank of
N/A
Yan XiongIndustrial and Commercial
60
Minglu ZhangPetroChina Co Ltd
60
Ja CPAChina Life Insurance
47
Walter BrandstaetterChina Construction Bank
N/A
Cansino Biologics (688185) is traded on Shanghai Stock Exchange in China and employs 1,494 people. Cansino Biologics is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Cansino Biologics Leadership Team

Elected by the shareholders, the Cansino Biologics' board of directors comprises two types of representatives: Cansino Biologics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cansino. The board's role is to monitor Cansino Biologics' management team and ensure that shareholders' interests are well served. Cansino Biologics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cansino Biologics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Yonghui Wu, Vice Marketing
Jin Cui, Board Secretary
Xuefeng Yu, Chairman, CoFounder
Tao Zhu, Deputy CoFounder
Chunlin Xin, Director Department
Xi Luo, Chief Officer
FCS FCIS, Joint Secretary
Dongxu MBA, Executive CoFounder
Jing Wang, Deputy Officer
ShouBai Chao, COO Director

Cansino Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cansino Biologics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Cansino Stock

Cansino Biologics financial ratios help investors to determine whether Cansino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cansino with respect to the benefits of owning Cansino Biologics security.